All current vaccines require constant updating to keep up with virus mutations.
Scientists say they have developed a universal vaccine against all 20 types of flu based on the same mRNA (MRNA) technology that was successfully used in coronavirus vaccines. The Air Force writes about it.
“All current vaccines require constant updating to keep up with virus mutations, and are unlikely to offer the same reliable protection,” said the drug’s developers.
While the new vaccine has only been tested in laboratory animals, clinical trials in humans are ahead. However, according to experts, a universal vaccine may appear in medical facilities as early as 2024.
The BBC said the two-dose vaccine uses the same array RNA (mRNA) technology used by Pfizer, BioNTech and Moderna to develop COVID vaccines.
“The mRNA is a molecule that contains the instructions for the cell to produce antibodies using its own internal mechanisms. To successfully enter the cell and not destroy it, the mRNA travels through a protective shell, which called lipid nanoparticles,” the article explains.
At the same time, as vaccine creators emphasize, it does not promise to end seasonal influenza once and for all, but it will greatly facilitate the work of doctors who are forced to change the vaccine formula every year in it is hoped that this will provide protection against new strains.
It should be noted that the Norwegian Public Health Institute (FHI) recorded the distribution of the new version of Omicron BF.7 in the country. This can cause an epidemic wave with a large number of patients.
news Correspondent.net on Telegram. Subscribe to our channel Athletistic
Source: korrespondent
I am Ben Stock, a passionate and experienced digital journalist working in the news industry. At the Buna Times, I write articles covering technology developments and related topics. I strive to provide reliable information that my readers can trust. My research skills are top-notch, as well as my ability to craft engaging stories on timely topics with clarity and accuracy.